The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Have just reread the Guident RNS after reading the latest post by Buywell3 on Adfvn. It appears Auve Tech have already started to deploy their Autonomous shuttles in Japan with as many as 4 in each of 50 locations planned for this year. Expect to see a steady news flow from Guident off the back of this.
Would be great to see a B2B RNS pre the presentation 😊 would really liven things up
Have found someone more optimistic than me about TEK’s prospects £1.56 by the end of 2025
https://theoakbloke.substack.com/p/136th-article-an-oak-bloke-top-20?utm_source=post-email-title&publication_id=1859293&post_id=141543804&utm_campaign=email-post-title&isFreemail=true&utm_medium=email&open=false&r=3cs1hx
High hopes for this one
A good informative read.
https://ukinvestormagazine.co.uk/microsalt-ipo-everything-you-need-to-know/
Https://www.factmr.com/report/regenerative-suspension-system-market
Regenerative Suspension System Market Outlook
The Regenerative Suspension System market is forecast to be worth $4.37 Billion in 2032
Key Companies:
- Audi
- Guident
- Intertronic Gresser GmbH
- Levant
- SoftWheel
- ZF
Taken from HME News - Direct sales exceeding expectations.
LONDON, PLANO, Texas, and SHENZHEN, China – Belluscura, a medical device developer focused on lightweight and portable oxygen technology, says early results on a two-month-old direct to consumer program for its X-PLOR device have exceeded initial expectations. The company has launched a three-pronged direct sales, leasing and short-term rental program for the device that has been well received by customers. "I am very excited about the new direct-to consumer sales program,” said Bob Fary, senior vice president of sales and marketing. “We have identified a potentially significant sales opportunity that not only benefits the company but underrepresented patients, as well." Belluscura sees the DTC program expanding significantly with the launch of the DISCOV-R portable oxygen concentrator. Earlier this month, Belluscura announced that it reached an agreement with TMT Acquisitions, a London-based acquisition vehicle in the technology, media and telecommunications sector, to help grow its portable oxygen concentrator business globally.
Yes get confidence from the fact TMTA have decided to put their money in here, would assume they would have looked long and hard first and asked plenty of questions regarding the capability to satisfy the 10,000+ orders. Good luck to you as well and with your TAK holding :)